1. Muntner P, He J, Hamm L, Loria C, Whelton PK. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States.
J Am Soc Nephrol 13:745–753. 2002;
2. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization.
Arch Intern Med 164:659–663. 2004;
3. Bolignano D, Lacquaniti A, Coppolino G, Donato V, Campo S, Fazio MR, Nicocia G, Buemi M. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease.
Clin J Am Soc Nephrol 4:337–344. 2009;
4. Ripley E. Complementary effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in slowing the progression of chronic kidney disease.
Am Heart J 157(6 Suppl):S7–S16. 2009;
5. Raebel MA. Hyperkalemia associated with use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Cardiovasc Ther 30:e156–e166. 2012;
6. Wang AY, Bellomo R, Ninomiya T, Lo S, Cass A, Jardine M, Gallagher M. Angiotensin-converting enzyme inhibitor usage and acute kidney injury: a secondary analysis of RENAL study outcomes.
Nephrology (Carlton) 19:617–622. 2014;
7. Ishani A, Xue JL, Himmelfarb J, Eggers PW, Kimmel PL, Molitoris BA, Collins AJ. Acute kidney injury increases risk of ESRD among elderly.
J Am Soc Nephrol 20:223–228. 2009;
8. Raff U, Schmidt BM, Schwab J, Schwarz TK, Achenbach S, Bär I, Schmieder RE. Renal resistive index in addition to low-grade albuminuria complements screening for target organ damage in therapy-resistant hypertension.
J Hypertens 28:608–614. 2010;
9. Florczak E, Januszewicz M, Januszewicz A, Prejbisz A, Kaczmarska M, Michałowska I, Kabat M, Rywik T, Rynkun D, Zieliński T, Kuśmierczyk-Droszcz B, Pregowska-Chwała B, Kowalewski G, Hoffman P. Relationship between renal resistive index and early target organ damage in patients with never-treated essential hypertension.
Blood Press 18:55–61. 2009;
10. Ikee R, Kobayashi S, Hemmi N, Imakiire T, Kikuchi Y, Moriya H, Suzuki S, Miura S. Correlation between the resistive index by Doppler ultrasound and kidney function and histology.
Am J Kidney Dis 46:603–609. 2005;
11. Radermacher J, Ellis S, Haller H. Renal resistance index and progression of renal disease.
Hypertension 39:699–703. 2002;
12. Sugiura T, Wada A. Resistive index predicts renal prognosis in chronic kidney disease.
Nephrol Dial Transplant 24:2780–2785. 2009;
13. Kim ES, Kim HJ, Kim YJ, Lee SM, Lee HJ, Cho DS, Son YK, Kim SE, Kim KH, An WS. Resistive index as a predictor of acute kidney injury caused by an angiotensin converting enzyme inhibitor or angiotensin II receptor blocker in chronic kidney disease patients.
Kidney Res Clin Pract 32:158–163. 2013;
14. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J. A new equation to estimate glomerular filtration rate.
Ann Intern Med 150:604–612. 2009;
15. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate.
Ann Intern Med 145:247–254. 2006;
16. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.
Am J Kidney Dis 39(2 Suppl 1):S1–S266. 2002;
17. Tangri N, Stevens LA, Griffith J, Tighiouart H, Djurdjev O, Naimark D, Levin A, Levey AS. A predictive model for progression of chronic kidney disease to kidney failure.
JAMA 305:1553–1559. 2011;
18. Lambers Heerspink HJ, Perkovic V, de Zeeuw D. Is doubling of serum creatinine a valid clinical ‘hard’ endpoint in clinical nephrology trials?
Nephron Clin Pract 119:c195–c199. discussion c199. 2011
19. Inaguma D, Imai E, Takeuchi A, Ohashi Y, Watanabe T, Nitta K, Akizawa T, Matsuo S, Makino H, Hishida A. Risk factors for CKD progression in Japanese patients: findings from the Chronic Kidney Disease Japan Cohort (CKD-JAC) study.
Clin Exp Nephrol Epub 2016 Jul 13.
20. Bigé N, Lévy PP, Callard P, Faintuch JM, Chigot V, Jousselin V, Ronco P, Boffa JJ. Renal arterial resistive index is associated with severe histological changes and poor renal outcome during chronic kidney disease.
BMC Nephrol 13:139.2012;
21. Parolini C, Noce A, Staffolani E, Giarrizzo GF, Costanzi S, Splendiani G. Renal resistive index and long-term outcome in chronic nephropathies.
Radiology 252:888–896. 2009;
22. Bader R, Bader H, Grund KE, Mackensen-Haen S, Christ H, Bohle A. Structure and function of the kidney in diabetic glomerulosclerosis. Correlations between morphological and functional parameters.
Pathol Res Pract 167:204–216. 1980;
23. Milovanceva-Popovska M, Dzikova S. Progression of diabetic nephropathy: value of intrarenal resistive index (RI).
Prilozi 28:69–79. 2007;
24. Kawai T, Kamide K, Onishi M, Yamamoto-Hanasaki H, Baba Y, Hongyo K, Shimaoka I, Tatara Y, Takeya Y, Ohishi M, Rakugi H. Usefulness of the resistive index in renal Doppler ultrasonography as an indicator of vascular damage in patients with risks of atherosclerosis.
Nephrol Dial Transplant 26:3256–3262. 2011;
25. Chan JC, Malik V, Jia W, Kadowaki T, Yajnik CS, Yoon KH, Hu FB. Diabetes in Asia: epidemiology, risk factors, and pathophysiology.
JAMA 301:2129–2140. 2009;
26. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.
BMJ 321:405–412. 2000;
27. Cooper CJ, Murphy TP, Cutlip DE, Jamerson K, Henrich W, Reid DM, Cohen DJ, Matsumoto AH, Steffes M, Jaff MR, Prince MR, Lewis EF, Tuttle KR, Shapiro JI, Rundback JH, Massaro JM, D’Agostino RB Sr, Dworkin LD. Stenting and medical therapy for atherosclerotic renal-artery stenosis.
N Engl J Med 370:13–22. 2014;
28. ASTRAL Investigators. Wheatley K, Ives N, Gray R, Kalra PA, Moss JG, Baigent C, Carr S, Chalmers N, Eadington D, Hamilton G, Lipkin G, Nicholson A, Scoble J. Revascularization versus medical therapy for renal-artery stenosis.
N Engl J Med 361:1953–1962. 2009;
29. Bax L, Woittiez AJ, Kouwenberg HJ, Mali WP, Buskens E, Beek FJ, Braam B, Huysmans FT, Schultze Kool LJ, Rutten MJ, Doorenbos CJ, Aarts JC, Rabelink TJ, Plouin PF, Raynaud A, van Montfrans GA, Reekers JA, van den Meiracker AH, Pattynama PM, van de Ven PJ, Vroegindeweij D, Kroon AA, de Haan MW, Postma CT, Beutler JJ. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial.
Ann Intern Med 150:840–848. W150–W151. 2009;
30. Textor SC, Lerman LO. Paradigm shifts in atherosclerotic renovascular disease: where are we now?
J Am Soc Nephrol 26:2074–2080. 2015;